Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
EV/EBIT
24.47 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its Earnings Before Interest and Taxes (EBIT). As of today, Teva Pharmaceutical Industries Ltd's enterprise value is $57,670 Mil. Teva Pharmaceutical Industries Ltd's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was $2,357 Mil. Therefore, Teva Pharmaceutical Industries Ltd's EV/EBIT ratio for today is 24.47.

TEVA' s EV/EBIT Range Over the Past 10 Years
Min: 12   Max: 991
Current: 24.47

12
991

During the past 13 years, the highest EV/EBIT Ratio of Teva Pharmaceutical Industries Ltd was 991.00. The lowest was 12.00. And the median was 20.55.

TEVA's EV/EBIT is ranked lower than
59% of the 591 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 21.71 vs. TEVA: 24.47 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Teva Pharmaceutical Industries Ltd's enterprise value for the quarter that ended in Mar. 2016 was $56,920 Mil. Teva Pharmaceutical Industries Ltd's earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was $2,357 Mil. Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2016 was 4.14%.


Definition

Teva Pharmaceutical Industries Ltd's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Earnings Before Interest and Taxes (EBIT) (TTM)
=57669.620/2357
=24.47

Teva Pharmaceutical Industries Ltd's current Enterprise Value is $57,670 Mil.
Teva Pharmaceutical Industries Ltd's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was 662 (Jun. 2015 ) + 2020 (Sep. 2015 ) + -1490 (Dec. 2015 ) + 1165 (Mar. 2016 ) = $2,357 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2016 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Mar. 2016 )=EBIT (TTM)/Enterprise Value (Q: Mar. 2016 )
=2357/56920.14
=4.14 %

Teva Pharmaceutical Industries Ltd's Enterprise Value for the quarter that ended in Mar. 2016 was $56,920 Mil.
Teva Pharmaceutical Industries Ltd's Earnings Before Interest and Taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2016 was 662 (Jun. 2015 ) + 2020 (Sep. 2015 ) + -1490 (Dec. 2015 ) + 1165 (Mar. 2016 ) = $2,357 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Earnings Yield (Joel Greenblatt), Earnings Before Interest and Taxes (EBIT)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebit 31.6115.6338.8021.8413.5525.6919.9229.8214.5134.03

Teva Pharmaceutical Industries Ltd Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebit 29.8232.0116.8915.4614.5116.2817.8813.5334.0324.15
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK